The very early stages of the business are the most crucial and daunting. Perhaps we can help you get through the early stages. We are here to help.
Our business solutions involves providing some initial feedback and advice on developing new products or improving existing technologies, improving processes, and improving designs.
Our business development is experiential and through the academic classroom setting. Experience in early-stage biotech company formation and product design and construction provides insights to assist in decision-making. Other expertise is in the field of Organizational Leadership and Entrepreneurial Leadership.
We consider global reach to consist of business initiatives that increase the visibility of the company with existing customers and future customers through the internet.
Financing private and public biotech deals will continue to focus on investors like the prior year (2021). According to Evaluate Pharma, biotechnology companies had a record-setting $24 billion in venture capital (VC) during the first three quarters of 2021, surpassing the nearly $20 billion raised in all of 2020. (Genetic Engineering and News, January 2022)
Talent and staffing will continue to be challenging since there are not enough trained scientific hands to staff many biotech companies. Recruitment and retention are top of mind for everyone in biotech (Geek wire, January 2022)
Artificial intelligence is emerging to fuel many of biotech's advances which can analyze enormous troves of data with accuracy and speed. And while AI's biotech applications focus on cancer breakthroughs and treatments. For example, AI to target cancers has grabbed the attention of investors.
During the last few years, mental health has made its way to the forefront of public consciousness. Two years of isolation from loved ones' jobs and financial stresses have people openly speaking about their anxiety, depression, trauma, and other mental health issues, which are undeniably a biotechnology health focus for 2022. New advances in technology such as wearables brain imaging and neuro-targeted therapeutics are in high demand during the unspoken health crisis of mental health.
Research and Development for SARS-CoV-2 Disease Control Methods
Treatment through therapeutic antibodies, therapeutic antivirals, and vaccines (whole virus, RNA or mRNA based, non-replicating viral vector, and protein subunit).
Surveillance through PCR (molecular) tests to detect genetic material of the virus to determine the presence of active infection with SARSCoV-2. Rapid Antigen tests to detect for pieces of proteins that make up the SARSCoV-2 virus to determine the presence of active infection with SARSCoV-2. Serology tests for antibodies against SARS-CoV-2 in the blood to determine if someone has been infected through a past exposure.
Prevention by wearing a face cover; washing your hands; and keeping a safe distance.
Vaccine Development and Distribution Strategies for Covid-19 and other needed vaccines.
Synthetic biology will continue to expand and develop by the ability to modify genes and use cells as medicines to alter the spread of human diseases. Also, synthetic biology will increasingly explore redesigning organisms to have the ability to impact manufacturing and green biotechnology such as agriculture.
Increased collaboration between academia and industry academic hubs serving as infant companies that can be nurtured and screened for tactical partnership with biotech or pharma companies.
Drug developments for Alzheimer’s disease will emerge in 2020. Biogen’s FDA filing for new drugs is promising. Biogen agreed to acquire from Pfizer Incorporated in January 2020 a novel drug for potential treatment of patients with behavioral and neurological symptoms. A common symptom is Sundowning in Alzheimer’s Disease. Sundowning is a symptom known as late-day confusion. (biogen)
A continuing trend for decades to come will be genome editing adoption beyond traditional human drug development. This will be implemented in many areas of biotechnology not only for humans but animal livestock, and animal agriculture. Veterinary Medicine will evolve like never before.
(genengnews, January 2020) “the launch of Prime Medicine by co-founders that include David Liu, PhD, of the Broad Institute of MIT and Harvard. Liu and associates genome editing does not make double-strand breaks in the target sequence or use a donor DNA template.” Prime editing technology is geared for creating or correcting any single-base transition mutations, as well as for the treatment of sickle cell disease.
Laboratory considerations for sterility verification.
Prescription drug app development for understanding the effects of prescription drug medications.
Dental app development for improving consumer oral care and awareness.
Expansion of New Cancer Drug (Chemical Toolbox) startup company in the United States.
Expansion of Maryland based company that specializes in high sensitivity pyrogen screening
Monitoring heart rate and pulse more accurately geared to different populations of people
Robotic Process Automation Technology Implementation With New And Up And Coming Biotech And Health Organizations 2021
Health Clinic Operations Planning 2021
Biotechnology Lab Skills Curriculum Development 2021
Health Insurance Program Development (Health, Dental, And Pet Coverage) 2021
Covid -19 Test Kits and Commercial Facility Sterilization
Digital Health Company Start Up for Underserved Communities of Color
Our experience spans from customer discovery, customer acquisition, market analysis, laboratory management, personnel management, organizational design, and organizational leadership theory. Grant writing, project management experience, networking experience, and business strategy are experiences that we can lend to assist in the early stages of your company.